US1879762A - Protection of autoxidizable materials - Google Patents
Protection of autoxidizable materials Download PDFInfo
- Publication number
- US1879762A US1879762A US515421A US51542131A US1879762A US 1879762 A US1879762 A US 1879762A US 515421 A US515421 A US 515421A US 51542131 A US51542131 A US 51542131A US 1879762 A US1879762 A US 1879762A
- Authority
- US
- United States
- Prior art keywords
- concentrate
- autoxidizable
- materials
- antioxidant
- protection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000463 material Substances 0.000 title description 9
- 239000012141 concentrate Substances 0.000 description 16
- 235000008504 concentrate Nutrition 0.000 description 15
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 14
- 239000003963 antioxidant agent Substances 0.000 description 13
- 230000003078 antioxidant effect Effects 0.000 description 12
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 7
- 239000001301 oxygen Substances 0.000 description 7
- 229910052760 oxygen Inorganic materials 0.000 description 7
- 239000000126 substance Substances 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 108010010803 Gelatin Proteins 0.000 description 5
- 229920000159 gelatin Polymers 0.000 description 5
- 239000008273 gelatin Substances 0.000 description 5
- 235000019322 gelatine Nutrition 0.000 description 5
- 235000011852 gelatine desserts Nutrition 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical class O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 230000006866 deterioration Effects 0.000 description 4
- 108010025899 gelatin film Proteins 0.000 description 4
- 230000001590 oxidative effect Effects 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 3
- 101100476962 Drosophila melanogaster Sirup gene Proteins 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000003026 cod liver oil Substances 0.000 description 2
- 235000012716 cod liver oil Nutrition 0.000 description 2
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000011362 coarse particle Substances 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- KOWWOODYPWDWOJ-LVBPXUMQSA-N elatine Chemical compound C([C@]12CN(C3[C@@]45OCO[C@]44[C@H]6[C@@H](OC)[C@@H]([C@H](C4)OC)C[C@H]6[C@@]3([C@@H]1[C@@H]5OC)[C@@H](OC)CC2)CC)OC(=O)C1=CC=CC=C1N1C(=O)CC(C)C1=O KOWWOODYPWDWOJ-LVBPXUMQSA-N 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
Definitions
- This invention relates to autoxidizable materials, particularly those used for therapeutic or alimentary purposes, and has for its object the provision of means whereby 5 such materials may be protected against the deteriorative effects of the atmosphere.
- My invention consists in interposing both mechanical and chemical barriers to the access of oxygen, by applying to the autoxidizable material an antioxidant and an impervious envelope.
- antioxidants especially aromatic hydroxyl derivatives and aliphatic and aromatic amines.
- impervious I mean highly obstructive to the passage of oxygen; that is to say, relatively airtight.
- the antioxidant may be directly admixed with the autoxidizable material; or superposed thereupon, in a suitable coat, above or belowthe impervious envelope; or distributed through the impervious envelope itself.
- vitaminous substances among them concentrates of the fat-soluble vitamins, particularly those obtained from cod-liver oil. These, notably as regards their vitamin- A content, are readily vitiated by exposure to oxygen; but my invention secures them against oxidative deterioration during the prolonged transportation and storage that, under the conditions of modern large-scale distribution, often intervene between manufacture and consumption.
- I may form such concentrates into tablets, and, successively, superpose upon them a coat in which hydroquinone is uniformly incorporated and enrobe them with a coherent film of gelatin.
- a coat in which hydroquinone is uniformly incorporated and enrobe them with a coherent film of gelatin.
- the coat and film are applied anaerically and comprise multiple layers.
- the finished tablet may, as a further precaution, be enclosed in a container from which the air has been displaced by an inert gas. Little, if any, air will penetrate the gelatin film; and whatever does infiltrate through it will come into contact with, and be rendered oxidatively innocuous by reaction with, the hydroquinone. Access of oxygen to the concentrate is thus substantially prevented.
- any other antioxidant e. g. one of those first above specified, may be employed; and the gelatin may be replaced by gelatinous starch, shellac, acacia, tragacanth, or some other gum or resinous varnish.
- the coats and films should be disintegrable in the gastric or intestinal fluids.
- the sugar or chocolate covering commonly used will do.
- the order and number of the coats and films, and of their re spective layers, are by no means invariable; and the antioxidant may be mingled with the concentrate or dissolved in the gelatin solution producing the film.
- fat-solublevitamin-concentrate tablets embodying my invention may be made as follows, air being preferably excluded, by evacuation or by substitution of carbon dioxide, from the vessels used in the process, and the ingredients having preferably been deaerated: A granulation is formed, in the customary manner, of an excipient comprising milk sugar 4.9 parts, cocoa powder 30 parts, powdered sugar 20 parts, and monohydrated sodium carbonate 1 part, and after the excessively fine and coarse particles have been removed by sifting, is impregnated with an ethereal solution of a fat-soluble-vitamin concentrate obtained from cod-liver oil.
- the granules are compressed into tablets and coated nine times with an antioxidant solution composed of simple sirupto which has been added 5% (calculated on the sucrose content) of hydroquinone. Then an impervious envelope is provided by applying, alternately with dusting powder to prevent the tablets from sticking together, six coats of a solution whose proportions are: gelatin 1 pound, sugar 25 pounds, water to make five gallons.
- a starch mixture is next applied, and last a finishing sirup; the respective volumes of which used for 135,000 tablets are 3% and 2 gallons; and the respective formulas of which are: granulated sugar 16 parts, water 7 parts, corn starch 4 parts, part, and erythrosin .0035 part; and simple sirup to every 4 gallons of which 3% grams of erythrosin has been added.
- the tablets are placed in bottles, which are then exhausted, flooded with carbon dioxide, and sealed.
- the granulation referred to may include .5 part of hydroquinone, in which event the antioxidant-containing coat is not required; and the tablets after compression, or suitably composed and rolled pill masses, may then be completed by twice dipping, to cover them by successive halves, into the gelatin solution.
- a tablet comprising a vitamin concentrate, an antioxidant distributed around the concentrate, and an impervious envelope over the antioxidant, the antioxidant being a substance that reacts so rapidly with any oxygen penetrating the envelope as substantially to prevent oxidative deterioration of the concentrate.
- a tablet comprising a fat-soluble-vitamin concentrate, an antioxidant distributed around the concentrate, and a elatin film over the antioxidant, the antioxi ant being a substance that reacts so rapidly with any oxygen penetrating thefilm as substantially to prevent oxidative deterioration of the concentrate.
- a tablet comprising a fat-soluble-vitamin concentrate, hydroquinone distributed on the surface of the concentrate, and a gelatin film over the hydroquinone.
- a tablet comprising a fat-soluble-vitamin concentrate, over the concentrate a coat in which hydroquinone is distributed, and
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Description
Patented Sept. 27, 1932 UNITED STATES PATENT OFFICE FERDINAND 'WQNITARDY, OF BROOKLYN, NEW YORK, ASSIGNOR T E. R. SQUIBB & SONS, OF NEW YORK, N. Y., A CORPORATION OF NEW YORK PROTECTION OF AUTOXIDIZABLE MATERIALS No Drawing.
This invention relates to autoxidizable materials, particularly those used for therapeutic or alimentary purposes, and has for its object the provision of means whereby 5 such materials may be protected against the deteriorative effects of the atmosphere.
My invention consists in interposing both mechanical and chemical barriers to the access of oxygen, by applying to the autoxidizable material an antioxidant and an impervious envelope. A great variety of substances may serve as antioxidants, especially aromatic hydroxyl derivatives and aliphatic and aromatic amines. By impervious I mean highly obstructive to the passage of oxygen; that is to say, relatively airtight. It will be understood that the antioxidant may be directly admixed with the autoxidizable material; or superposed thereupon, in a suitable coat, above or belowthe impervious envelope; or distributed through the impervious envelope itself. By virtue of the cooperation between these mechanical and chemical barriers, the one excluding or neutralizing such oxygen as may, by any chance, have passed the other, autoxidiziable materials can be preserved for an indefinite period from oxidative deterioration. .l'
Conspicuous among the numerous materials to the protection of which my invention is adapted, are vitaminous substances, among them concentrates of the fat-soluble vitamins, particularly those obtained from cod-liver oil. These, notably as regards their vitamin- A content, are readily vitiated by exposure to oxygen; but my invention secures them against oxidative deterioration during the prolonged transportation and storage that, under the conditions of modern large-scale distribution, often intervene between manufacture and consumption.
As an example, I may form such concentrates into tablets, and, successively, superpose upon them a coat in which hydroquinone is uniformly incorporated and enrobe them with a coherent film of gelatin. Preferably,
' the coat and film are applied anaerically and comprise multiple layers. An outer coat to give any desired flavor or color and to safe- 50 guard the gelatin film from physical dam- Application flied February 12, 1931. Serial No. 515,421.
age, may also be provided; and the finished tablet may, as a further precaution, be enclosed in a container from which the air has been displaced by an inert gas. Little, if any, air will penetrate the gelatin film; and whatever does infiltrate through it will come into contact with, and be rendered oxidatively innocuous by reaction with, the hydroquinone. Access of oxygen to the concentrate is thus substantially prevented.
Instead of hydroquinonc, any other antioxidant, e. g. one of those first above specified, may be employed; and the gelatin may be replaced by gelatinous starch, shellac, acacia, tragacanth, or some other gum or resinous varnish. Ordinarily, the coats and films should be disintegrable in the gastric or intestinal fluids. For the outer coat, the sugar or chocolate covering commonly used will do. As previusly suggested, the order and number of the coats and films, and of their re spective layers, are by no means invariable; and the antioxidant may be mingled with the concentrate or dissolved in the gelatin solution producing the film.
As a more specific example, fat-solublevitamin-concentrate tablets embodying my invention may be made as follows, air being preferably excluded, by evacuation or by substitution of carbon dioxide, from the vessels used in the process, and the ingredients having preferably been deaerated: A granulation is formed, in the customary manner, of an excipient comprising milk sugar 4.9 parts, cocoa powder 30 parts, powdered sugar 20 parts, and monohydrated sodium carbonate 1 part, and after the excessively fine and coarse particles have been removed by sifting, is impregnated with an ethereal solution of a fat-soluble-vitamin concentrate obtained from cod-liver oil. Upon volatilization of the solvent, the granules are compressed into tablets and coated nine times with an antioxidant solution composed of simple sirupto which has been added 5% (calculated on the sucrose content) of hydroquinone. Then an impervious envelope is provided by applying, alternately with dusting powder to prevent the tablets from sticking together, six coats of a solution whose proportions are: gelatin 1 pound, sugar 25 pounds, water to make five gallons. A starch mixture is next applied, and last a finishing sirup; the respective volumes of which used for 135,000 tablets are 3% and 2 gallons; and the respective formulas of which are: granulated sugar 16 parts, water 7 parts, corn starch 4 parts, part, and erythrosin .0035 part; and simple sirup to every 4 gallons of which 3% grams of erythrosin has been added. When completed, the tablets are placed in bottles, which are then exhausted, flooded with carbon dioxide, and sealed. Optionally, the granulation referred to may include .5 part of hydroquinone, in which event the antioxidant-containing coat is not required; and the tablets after compression, or suitably composed and rolled pill masses, may then be completed by twice dipping, to cover them by successive halves, into the gelatin solution.
It is to be understood that the foregoing embodiments are merely illustrative and not definitive of my invention, which may assume various other forms-for instance, as to the particular autoxidizable material, antioxidant, or impervious envelope, and the specific procedures followed-within the see e of the appended claims.
claim:
1. A tablet comprising a vitamin concentrate, an antioxidant distributed around the concentrate, and an impervious envelope over the antioxidant, the antioxidant being a substance that reacts so rapidly with any oxygen penetrating the envelope as substantially to prevent oxidative deterioration of the concentrate.
2. A tablet comprising a fat-soluble-vitamin concentrate, an antioxidant distributed around the concentrate, and a elatin film over the antioxidant, the antioxi ant being a substance that reacts so rapidly with any oxygen penetrating thefilm as substantially to prevent oxidative deterioration of the concentrate.
3. A tablet comprising a fat-soluble-vitamin concentrate, hydroquinone distributed on the surface of the concentrate, and a gelatin film over the hydroquinone.
4. A tablet comprising a fat-soluble-vitamin concentrate, over the concentrate a coat in which hydroquinone is distributed, and
over the coat a gelatin film. 7
In witness whereof I aflix my signature. FERDINAND W. NITARDY.
alcohol .24 part, oil of spearmint .06 i
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US515421A US1879762A (en) | 1931-02-12 | 1931-02-12 | Protection of autoxidizable materials |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US515421A US1879762A (en) | 1931-02-12 | 1931-02-12 | Protection of autoxidizable materials |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US1879762A true US1879762A (en) | 1932-09-27 |
Family
ID=24051290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US515421A Expired - Lifetime US1879762A (en) | 1931-02-12 | 1931-02-12 | Protection of autoxidizable materials |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US1879762A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2426762A (en) * | 1945-04-16 | 1947-09-02 | Scient Nutrition Corp | Composition of matter |
| US2912332A (en) * | 1958-02-27 | 1959-11-10 | Swift & Co | Stabilized thiamine composition and method of enriching food products |
| US3100783A (en) * | 1958-06-26 | 1963-08-13 | Philips Corp | Method of stabilizing crystalline compounds against oxidation |
| US3110598A (en) * | 1959-09-08 | 1963-11-12 | Hoffmann La Roche | Process of making a carotenoid preparation |
| US3124510A (en) * | 1964-03-10 | Stable dry powdered fat-soluble | ||
| US4389419A (en) * | 1980-11-10 | 1983-06-21 | Damon Corporation | Vitamin encapsulation |
| US5750145A (en) * | 1995-07-28 | 1998-05-12 | Bristol-Myers Squibb Company | Stable gelatin coated aspirin tablets |
-
1931
- 1931-02-12 US US515421A patent/US1879762A/en not_active Expired - Lifetime
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3124510A (en) * | 1964-03-10 | Stable dry powdered fat-soluble | ||
| US2426762A (en) * | 1945-04-16 | 1947-09-02 | Scient Nutrition Corp | Composition of matter |
| US2912332A (en) * | 1958-02-27 | 1959-11-10 | Swift & Co | Stabilized thiamine composition and method of enriching food products |
| US3100783A (en) * | 1958-06-26 | 1963-08-13 | Philips Corp | Method of stabilizing crystalline compounds against oxidation |
| US3110598A (en) * | 1959-09-08 | 1963-11-12 | Hoffmann La Roche | Process of making a carotenoid preparation |
| US4389419A (en) * | 1980-11-10 | 1983-06-21 | Damon Corporation | Vitamin encapsulation |
| US5750145A (en) * | 1995-07-28 | 1998-05-12 | Bristol-Myers Squibb Company | Stable gelatin coated aspirin tablets |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US1879762A (en) | Protection of autoxidizable materials | |
| US5912011A (en) | Solvent system to be enclosed in capsules | |
| TWI400073B (en) | Stable laquinimod preparations | |
| EP2111126B1 (en) | Improved stability in vitamin and mineral supplements | |
| US3136692A (en) | Effervescent composition containing polyvinylpyrrolidone | |
| US2887438A (en) | Prolonged action tablets | |
| DE60108376T3 (en) | METHOD FOR PRODUCING A BLISTER PACK FOR TOPIRAMATE TABLETS | |
| US2757124A (en) | Tablets and method of producing same | |
| RU2466741C2 (en) | Composition and method with using stabilised sensitive ingredient | |
| ES347190A1 (en) | Certain 3-pyridylmethyl-2-(p-chloro phenoxy)-2-methyl propionate-n-oxides and derivatives thereof | |
| US2508477A (en) | Enriched foodstuffs | |
| US3125491A (en) | Chew able hematinic vitamin tablet | |
| WO2007109824A1 (en) | Stable packaged dosage form and process therefor | |
| US2314527A (en) | Method of making sealed capsules | |
| CN119632836A (en) | Individual dose packaging | |
| US3196078A (en) | Process for combating retinits pigmentosa | |
| EP0025686A2 (en) | Pharmaceutical composition containing paracetamol, treatment pack comprising said composition and method of reducing liver toxicity effect of paracetamol compositions | |
| EP0335982B1 (en) | Gelatin composition | |
| US2853421A (en) | Gelatin pan coating | |
| US2519487A (en) | Multivitamin preparation | |
| US3419657A (en) | Iodopanoic acid in a hydrogel | |
| JPS63243034A (en) | Solid agent containing low-melting substance | |
| CN111773197A (en) | Novel alfacalcidol soft capsule and preparation method thereof | |
| CA3010865A1 (en) | Food based delivery of therapeutic agent for treatment of hepatic encephalopathy | |
| GB908282A (en) | Coated pharmaceutical granules and tablets thereof |